Cervical cancer screening

Last reviewed: 9 Nov 2022
Last updated: 14 Jun 2022

Summary

Details

  • Cervical sampling techniques
  • Cervical cytology
  • HPV testing
  • HPV vaccination
  • Colposcopy
  • Screening
Full details

Contributors

Authors

Richard T. Penson, MD, MRCP
Richard T. Penson

Clinical Director

Medical Gynecologic Oncology

Division of Hematology Oncology

Massachusetts General Hospital

Boston

MA

Disclosures

RTP has received institutional research funding from Array BioPharma Inc., AstraZeneca, Genentech, and Vascular Biogenics Ltd. RTP has been paid for participating in scientific advisory boards for: AbbVie, AstraZeneca, Clovis Oncology, Curio Science, Eisai Inc., Genentech, Janssen Oncology (J&J), Merck & Co., Mersana Therapeutics, Inc., NewLink Genetics, Nexus Global Group, Pieris Pharma Inc, Roche, Inc., Sutro Biopharma, Syndax Pharmaceuticals, Tesaro Inc., and Vascular Biogenics Ltd.

Marcela G. del Carmen, MD, MPH
Marcela G. del Carmen

Chief Medical Officer

Massachusetts General Physicians Organization

Division of Gynecologic-Oncology

Massachusetts General Hospital

Professor

Department of Obstetrics, Gynecology and Reproductive Biology

Harvard Medical School

Boston

MA

Disclosures

MDC declares that she has no competing interests.

Peer reviewers

Deirdre Lyons, MB, BCh, BAO, MRCOG

Consultant in Obstetrics & Gynaecology

Lead Clinician in Colposcopy

Imperial College Healthcare NHS Trust

London

UK

Disclosures

DL declares that she has no competing interests.

Matejka Rebolj, PhD

Scientific Researcher

Centre for Epidemiology and Screening

Institute of Public Health

University of Copenhagen

Copenhagen

Denmark

Disclosures

MR declares that she has no competing interests.

Shagufta Yasmeen, MD

Associate Professor

Department of Obstetrics and Gynecology

UC Davis Health System

Sacramento

CA

Disclosures

SY declares that she has no competing interests.

Use of this content is subject to our disclaimer